OVEREXPRESSION OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR IN PANCREATIC-CANCER - EVALUATION OF ITS BIOLOGICAL FUNCTION AS A GROWTH-FACTOR

Citation
Y. Ohmachi et al., OVEREXPRESSION OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR IN PANCREATIC-CANCER - EVALUATION OF ITS BIOLOGICAL FUNCTION AS A GROWTH-FACTOR, International journal of pancreatology, 15(1), 1994, pp. 65-73
Citations number
35
Categorie Soggetti
Endocrynology & Metabolism",Physiology
ISSN journal
01694197
Volume
15
Issue
1
Year of publication
1994
Pages
65 - 73
Database
ISI
SICI code
0169-4197(1994)15:1<65:OOPSTI>2.0.ZU;2-W
Abstract
Four clones of pancreatic secretory trypsin inhibitor (PSTI)-overexpre ssing cells (TF-PANC clones 1, 6, 8, and 36) were established to evalu ate the physiological function of PSTI secreted by cancer cells, by me ans of introducing a PSTI-expression vector (pRSV-PSTI) into the human pancreatic adenocarcinoma cell line (PANC-1). No obvious changes were observed in the histological features of these transplanted tumors in nude mice, in the growth of TF-PANC and PANC-1, or that of 3T3 fibrob lasts when cocultured with them. Addition of recombinant human PSTI to the cultured media resulted in no increase in proliferation of fibrob lasts (3T3 and WI-38) or of four pancreatic cancer cell lines (PANC-1, CAPAN-I, MIAPaCa-2, and Hs766T). These results suggest that the estim ation of tumor-bearing PSTI as a paracrine or autocrine growth factor in recent studies should be given careful consideration.